Manufacture

Will bacteriophages be the savior of the human race in the post-antibiotic era or is it just pie in the sky?

By mimicking natural evolution of enzymes, researchers are creating biocatalysts for reactions unheard of in nature.

But can pharma manufacturers do more to help prevent medication errors?

What impact will genetic changes have on new medicines currently in development?

By eliminating protein A, researchers aim to deliver continuous processing at a fraction of the cost of conventional techniques.

We speak to Professor Begoña Calvo to find out more about her research into pharmaco vigilance for biosimilars.

The first US biosimilar has been pocketed and the game is on. We bring six experts to the table to discuss the impact on industry dynamics.

The industry has been dipping its toe into the water of continuous manufacturing for years.

An antimalarial medicine-making project wins the inaugural Humanity in Science Award.

We catch up with Carol Lynch, Global Head of Biopharmaceuticals & Oncology Injectables at Sandoz.